GlassScriptPhysician profile
Fredric Howard Itzkowitz
NPI 1649266362
$1,610.05
in general payments reported to CMS, 2019-2025
28 companies · $61.10 in 2025
The $61.10 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $514 · 2020: $18.77 · 2021: $69.73 · 2022: $54.35 · 2023: $395 · 2024: $497 · 2025: $61.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $935 · Education: $18.09.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $934.71 |
| Education | $18.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $288.00 | 2024 | |
| Stryker Corporation | $148.85 | 2019 | |
| Ethicon US, LLC | $130.52 | 2019-2024 | Echelon Flex, Echelon Circular |
| Kci USA, INC. | $118.09 | 2019-2023 | Prevena, V.A.C. Veraflo, V.A.C.Ulta |
| Sirius Medical Systems | $113.02 | 2023-2024 | Pintuition |
| Endomagnetics LTD | $102.11 | 2019 | |
| Leica Microsystems INC. | $96.10 | 2019 | |
| Teleflex LLC | $92.98 | 2023 | Instruments: General |
| Merck Sharp & Dohme LLC | $71.38 | 2019-2024 | Bridion, Lynparza, Keytruda |
| Integra Lifesciences Corporation | $59.10 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Haemonetics Corporation | $50.48 | 2023 | Teg6s Hemostasis System |
| Hologic Sales and Service, LLC | $37.89 | 2023 | Trunode, Localizer |
| Smith+Nephew, INC. | $32.95 | 2024 | Renasys Go V2 Home |
| Aroa Biosurgery Incorporated | $29.46 | 2024 | |
| Acelrx Pharmaceuticals, INC. | $27.77 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $23.80 | 2024 | Ligasure |
| Genentech USA, INC. | $20.12 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $19.42 | 2025 | |
| Heron Therapeutics, INC. | $15.99 | 2024 | Zynrelef |
| Solventum Corporation | $15.96 | 2024 | Prevena |
| Elucent Medical | $15.84 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $15.49 | 2021 | |
| Dilon Technologies, INC. | $15.06 | 2023 | Hemoblast Bellows |
| Hologic INC | $14.84 | 2022 | |
| Angiodynamics, INC. | $14.41 | 2022 | |
| Covidien LP | $14.14 | 2019 | |
| Convatec INC. | $13.34 | 2022 | |
| Abbvie INC. | $12.94 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fredric Itzkowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.